“Companies are doing their best to accelerate experimental drugs and vaccines for COVIDcampaign-pages/bispecifics/-19 through the pipeline… On 11 March, Eli Lilly announced its intention to co-develop the COVIDcampaign-pages/bispecifics/-19 mAbs discovered by AbCellera.”
Read full coverage on Nature Biotechnology News.